Applying Mechanistic PK/PD Modeling Approaches in Preclinical Research


John M. Burke, PhD, Co-founder, President and CEO at Applied BioMath


In part two of this three-part GENcast series, we dive into the various aspects of the drug discovery and development process and, in particular, how advanced computational techniques like mechanistic modeling can accelerate the therapeutic drug pipeline for developers. Dr. John Burke, President, CEO, and Co-founder of Applied BioMath, delves deeper into the specific applications of mechanistic modeling and how Applied BioMath helps biotech and pharma organizations reduce late-stage drug attrition rates.

View our other podcasts in this GENcast series

What is Mechanistic Modeling and How Can it be Applied in Drug Discovery?

Mechanistic Modeling in Clinical Development